Morgan Stanley’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68M Buy
526,842
+8,206
+2% +$1.18M ﹤0.01% 1792
2025
Q4
$74M Sell
518,636
-46,550
-8% -$6.24M ﹤0.01% 1722
2025
Q3
$67.8M Buy
565,186
+26,759
+5% +$3.39M ﹤0.01% 1744
2025
Q2
$71.2M Sell
538,427
-38,533
-7% -$5.22M ﹤0.01% 1603
2025
Q1
$80.1M Sell
576,960
-43,271
-7% -$6.72M 0.01% 1414
2024
Q4
$96.2M Buy
620,231
+7,813
+1% +$1.32M 0.01% 1276
2024
Q3
$112M Buy
612,418
+41,937
+7% +$6.21M 0.01% 1166
2024
Q2
$67.7M Sell
570,481
-80,240
-12% -$8.44M 0.01% 1467
2024
Q1
$69.8M Sell
650,721
-518,545
-44% -$51.6M 0.01% 1455
2023
Q4
$117M Buy
1,169,266
+517,440
+79% +$50.6M 0.01% 1568
2023
Q3
$77.6M Buy
651,826
+28,896
+5% +$4.31M 0.01% 1228
2023
Q2
$111M Sell
622,930
-68,061
-10% -$12.5M 0.01% 1025
2023
Q1
$114M Buy
690,991
+11,079
+2% +$1.91M 0.01% 990
2022
Q4
$107M Buy
679,912
+476,012
+233% +$72.4M 0.01% 988
2022
Q3
$30.7M Buy
203,900
+91,244
+81% +$15.2M ﹤0.01% 1749
2022
Q2
$18.5M Buy
112,656
+83,230
+283% +$16M ﹤0.01% 2377
2022
Q1
$6.55M Buy
29,426
+5,375
+22% +$1.2M ﹤0.01% 3385
2021
Q4
$5.71M Sell
24,051
-5,561
-19% -$1.3M ﹤0.01% 3577
2021
Q3
$6.91M Buy
29,612
+4,708
+19% +$987K ﹤0.01% 3338
2021
Q2
$5.12M Buy
24,904
+15,253
+158% +$3.14M ﹤0.01% 3758
2021
Q1
$1.98M Sell
9,651
-9,845
-50% -$2.08M ﹤0.01% 4266
2020
Q4
$4.18M Buy
19,496
+12,126
+165% +$2.35M ﹤0.01% 3452
2020
Q3
$1.35M Sell
7,370
-46
-0.6% -$8.66K ﹤0.01% 3994
2020
Q2
$1.37M Sell
7,416
-684
-8% -$136K ﹤0.01% 3925
2020
Q1
$1.64M Sell
8,100
-52,728
-87% -$10.1M ﹤0.01% 3541
2019
Q4
$11.4M Buy
60,828
+55,760
+1,100% +$9.6M ﹤0.01% 2284
2019
Q3
$809K Buy
5,068
+120
+2% +$23.9K ﹤0.01% 4423
2019
Q2
$1.25M Sell
4,948
-7,586
-61% -$1.76M ﹤0.01% 4104
2019
Q1
$3M Sell
12,534
-1,441
-10% -$346K ﹤0.01% 3221
2018
Q4
$3.21M Sell
13,975
-13,263
-49% -$3.27M ﹤0.01% 3364
2018
Q3
$7.7M Sell
27,238
-49,120
-64% -$14.4M ﹤0.01% 2693
2018
Q2
$22.4M Buy
76,358
+8,631
+13% +$2.36M 0.01% 1530
2018
Q1
$17.1M Buy
67,727
+30,881
+84% +$7.26M ﹤0.01% 1810
2017
Q4
$7.96M Buy
36,846
+10,015
+37% +$2.03M ﹤0.01% 2627
2017
Q3
$4.99M Buy
26,831
+6,612
+33% +$1.15M ﹤0.01% 2960
2017
Q2
$3.49M Sell
20,219
-3,827
-16% -$614K ﹤0.01% 3264
2017
Q1
$3.67M Sell
24,046
-26,139
-52% -$3.82M ﹤0.01% 3206
2016
Q4
$7.39M Buy
50,185
+42,438
+548% +$6.14M ﹤0.01% 2581
2016
Q3
$979K Buy
7,747
+3,675
+90% +$443K ﹤0.01% 4061
2016
Q2
$459K Sell
4,072
-417
-9% -$43.3K ﹤0.01% 4478
2016
Q1
$467K Sell
4,489
-48,835
-92% -$4.67M ﹤0.01% 4493
2015
Q4
$6.01M Sell
53,324
-26,137
-33% -$2.89M ﹤0.01% 2482
2015
Q3
$8.7M Sell
79,461
-2,380
-3% -$255K ﹤0.01% 2105
2015
Q2
$7.83M Buy
81,841
+17,846
+28% +$1.67M ﹤0.01% 2359
2015
Q1
$5.96M Sell
63,995
-31,296
-33% -$2.74M ﹤0.01% 2594
2014
Q4
$7.8M Buy
95,291
+58,839
+161% +$4.51M ﹤0.01% 2309
2014
Q3
$2.34M Buy
36,452
+14,757
+68% +$904K ﹤0.01% 3301
2014
Q2
$1.32M Sell
21,695
-347
-2% -$20.5K ﹤0.01% 3825
2014
Q1
$1.32M Buy
22,042
+3,262
+17% +$201K ﹤0.01% 3767
2013
Q4
$1.2M Sell
18,780
-94,730
-83% -$6.1M ﹤0.01% 3780
2013
Q3
$7.71M Buy
113,510
+68,905
+154% +$4.92M ﹤0.01% 2010
2013
Q2
$3.21M Buy
+44,605
New +$2.95M ﹤0.01% 2738

Other funds holding ICUI

Morgan Stanley's ICUI Position: Q1 2026 in Review

Morgan Stanley increased its ICU Medical (ICUI) stake by 1.6% in Q1 2026, buying an estimated $1.18M and bringing the position to 526,842 shares worth $68M. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Morgan Stanley first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $117M in Q4 2023. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Morgan Stanley held 526,842 shares of ICU Medical worth $68M as of Q1 2026.
  • Morgan Stanley bought 8,206 ICU Medical shares in Q1 2026, an estimated $1.18M.
  • ICU Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #1792 holding.
  • Morgan Stanley first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's ICU Medical position peaked at $117M in Q4 2023.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.